Holly Hagan
Holly Hagan
Professor Emeritus
-
Professional overview
-
Dr. Holly Hagan is Professor Emeritus at the School of Global Public Health. Trained as an infectious disease epidemiologist, Dr. Hagan’s work has sought to understand the causes and consequences of substance use disorders. Her research has examined blood-borne and sexually-transmitted infections among people who use drugs. She is an internationally-recognized expert in the etiology, epidemiology, natural history, prevention and treatment of hepatitis C virus infection among PWUD, and in 2014 her work was recognized by the US Department of Health and Human Services with the President’s Award for Leadership in the Control of Viral Hepatitis in the United States. Dr. Hagan served on the Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis in the United States, and she has been an advisor to the US Department of Health and Human Services, the CDC, and the Canadian Institutes of Health on national programs to detect, diagnose and treat HCV infections. She was recently appointed to the National Academy of Medicine Committee on the Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs.
Dr. Hagan is the Director of the NIDA P30 Center for Drug Use and HIV|HCV Research at Global Public Health, which provides research support to investigators throughout NYU and in two other NYC institutions. In 2017, she was selected by NIDA to chair the Executive Steering Committee for the Rural Opioid Initiative funded by NIH, CDC, SAMHSA and the Appalachian Regional Commission. Her research has shifted to examining the impact of the opioid crisis more broadly, to include studying the epidemiology of fatal and non-fatal overdose among PWUD. She was chosen by the American Foundation for AIDS Research to be the Principal Investigator for the New York State Opioid Prevention Center pilot study, which will examine the safety and effectiveness of the Supervised Consumption Sites to be implemented in New York City and in upstate NY.
-
Education
-
PhD Epidemiology, University of Washington, Seattle, WAMPH Epidemiology, University of Massachusetts, Amherst, MABA Russian Studies, Evergreen State College, Olympia, WA
-
Publications
Publications
HIV among injecting drug users
Failed retrieving data.Drug use
Failed retrieving data.Emerging infectious diseases and the injection of illicit psychoactive substances
Failed retrieving data.HIV among injecting drug users : Epidemiology and emerging public health perspectives
Failed retrieving data.Injection drug use and emerging blood-borne diseases [2]
Failed retrieving data.The protective effect of AIDS-related behavioral change among injection drug users : A cross-national study
Failed retrieving data.Maintaining low HIV seroprevalence in populations of injecting drug users
Failed retrieving data.Management of children with hypodermic needle injuries
Failed retrieving data.Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program
Failed retrieving data.An interview study of participants in the Tacoma, Washington, syringe exchange
Failed retrieving data.Studies of HIV/AIDS and injecting drug use
Failed retrieving data.The Incidence of HBV Infection and Syringe Exchange Programs
Failed retrieving data.The tacoma syringe exchange
Failed retrieving data.The Tacoma syringe exchange
Failed retrieving data.Letters to the Editor
Failed retrieving data.